Categories: Prescription Medication
Description:
Docetaxel is a chemotherapy drug commonly used in combination with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC), especially in men with high-volume or symptomatic disease. It works by inhibiting cancer cell division and promoting cell death.
When added to ADT, docetaxel has been shown to improve overall survival in large clinical trials (e.g., CHAARTED, STAMPEDE), particularly in patients with extensive bone or visceral metastases. It is typically given as 6 cycles every 3 weeks. Side effects can include fatigue, low blood counts, neuropathy, and risk of infection, so it is best suited for patients with good performance status.
Treatment For:
AI generated Summary: Based on the provided information, there are no reviews available for the treatment "Docetaxel" against the disease "Prostate Cancer, Metastatic hormone-sensitive prostate cancer." Without any user reviews or ratings, it is not possible to determine the effectiveness of this treatment for the specified condition based solely on the given data.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
